Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NuVasive

Explore full profile

Medical device company developing minimally disruptive surgical products and procedurally integrated solutions for the spine

San Diego, United StatesFounded 1997Biotech & Life Sciences
Valuation $3.10B Market cap · 2026
Revenue $1.20B Latest reported FY
EBITDA $212M Latest reported FY

At a glance

Founded
1997
Headquarters
San Diego, United States
Listing
IPO 2004
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning NuVasive.

See all news

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 9 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
26 countries with
team presence
🇺🇸 United States77.2%
🇧🇷 Brazil3.8%
🇩🇪 Germany3.1%
🇦🇺 Australia2.9%
🇳🇱 Netherlands2.6%
Top 5 of 26 shown
Web traffic by country
85K monthly visits
across markets
🇺🇸 United States91.6%
🇮🇳 India3.1%
🇬🇧 United Kingdom2%
🇪🇸 Spain1.4%
🇧🇷 Brazil1.1%
Top 5 markets shown

Patents

Estimated portfolio value
$292M

327 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where NuVasive was the backer or acquirer, 2016–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across NuVasive's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where NuVasive deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        NuVasive's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about NuVasive on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See NuVasive on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.